Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Not yet recruiting

Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC

NCT04153734

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Prognosis and Predicting Genetic Study of Lung Cancer

NCT03234179

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

NCT01595074

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada

View Trial Details

Enrolling by invitation

Harvesting Cells for Experimental Cancer Treatments

NCT00068003

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +31 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Enrolling by invitation

Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC

NCT07738367

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Fujian Cancer Hospital Fuzhou, Fujian, China

View Trial Details

Enrolling by invitation

Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study

NCT07373899

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Chaoyang, China

View Trial Details

Enrolling by invitation

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

NCT07218003

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +54 more
Locations: UCSF Medical Center San Francisco, California, United States

Yale Cancer Center New Haven, Connecticut, United States

START Midwest Grand Rapids, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Enrolling by invitation

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

NCT06885424

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +67 more
Locations: Banner Health Gilbert, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

NYU Langone Medical Center New York, United States

View Trial Details

Enrolling by invitation

Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.

NCT06281964

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Guangdong Provincial People's Hospital Guangzhou, China

View Trial Details

Enrolling by invitation

Sarcopenia and Cachexia in Patients With Lung Cancer

NCT06730685

Conditions: Atrophy, Body Weight, Body Weight Changes, +24 more
Locations: Zealand University Hospital Næstved, Region Sjælland, Denmark

View Trial Details